SYSTEMATIC REVIEW article
Front. Psychol.
Sec. Psycho-Oncology
This article is part of the Research TopicInnovations in Psychological Care for Oncology and Palliative Settings: A Holistic ApproachView all 12 articles
Assessment Instruments and Psychological Treatments for Fear of Recurrence in Oncohematological Patients: A Systematic Review
Provisionally accepted
- 1Universidad a Distancia de Madrid, Madrid, Spain
- 2Hospital Universitario La Paz, Madrid, Spain
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Introduction: Oncohematological patients undergo a complex emotional adaptation process, in which Fear of Cancer Recurrence (FCR) is one of the most prevalent concerns. This fear not only negatively impacts their psychological well-being but is also associated with a significant reduction in quality of life. Objective: This study aims to conduct a systematic review of the available evidence regarding: 1) The factors associated with FCR in oncohematological patients. 2) The validity and reliability of the instruments used for its assessment. 3) The therapeutic interventions designed to mitigate FCR in this population, with particular focus on those supported by solid empirical evidence. Methodology: A systematic review was conducted following the PRISMA guidelines. The literature search was performed in November 2024 across the PubMed, PsycINFO, Web of Science, ProQuest, SUMMON, SciELO, Redalyc, Dialnet, and Google Scholar databases. Rigorous inclusion and exclusion criteria were applied to ensure the methodological quality of the selected studies. Results: After the selection process, 11 studies meeting the eligibility criteria were included. The main findings were: a) FCR assessment instruments: Four validated tools specifically designed for oncohematological populations were identified. b) Therapeutic interventions: Four programs based on cognitive-behavioral therapy and third-wave therapies were found to be effective in reducing FCR in patients with leukemia, lymphoma, and multiple myeloma. Conclusions: This systematic review provides a comparative evaluation of measurement methods and the most effective interventions for addressing FCR in oncohematological patients. The findings highlight the need for further research tailored to the specific characteristics of this population, fostering the development of more precise and accessible therapeutic strategies.
Keywords: Hematologic cancer, assessment, therapy, Quality of Life, Fear of recurrence
Received: 26 May 2025; Accepted: 24 Oct 2025.
Copyright: © 2025 Martínez, Rueda-Extremera, Alejandre-Carmona and Cantero-García. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: María Cantero-García, maria.canterogar@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.